nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP3A7—Dapsone—systemic lupus erythematosus	0.0476	0.0705	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0476	0.0705	CbGbCtD
Nefazodone—CYP3A5—Dapsone—systemic lupus erythematosus	0.0357	0.0529	CbGbCtD
Nefazodone—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.0331	0.049	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.0331	0.049	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.0313	0.0463	CbGbCtD
Nefazodone—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.0313	0.0463	CbGbCtD
Nefazodone—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.031	0.0458	CbGbCtD
Nefazodone—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0266	0.0394	CbGbCtD
Nefazodone—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0249	0.0368	CbGbCtD
Nefazodone—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0235	0.0347	CbGbCtD
Nefazodone—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.0206	0.0305	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.0206	0.0305	CbGbCtD
Nefazodone—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0202	0.0298	CbGbCtD
Nefazodone—ABCB1—Betamethasone—systemic lupus erythematosus	0.0173	0.0256	CbGbCtD
Nefazodone—ABCB1—Prednisolone—systemic lupus erythematosus	0.0171	0.0253	CbGbCtD
Nefazodone—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0162	0.0239	CbGbCtD
Nefazodone—ABCB1—Prednisone—systemic lupus erythematosus	0.0161	0.0239	CbGbCtD
Nefazodone—HTR2C—choroid plexus—systemic lupus erythematosus	0.0161	0.227	CbGeAlD
Nefazodone—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0159	0.0236	CbGbCtD
Nefazodone—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.0155	0.0229	CbGbCtD
Nefazodone—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0153	0.0226	CbGbCtD
Nefazodone—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0144	0.0213	CbGbCtD
Nefazodone—CYP3A4—Dapsone—systemic lupus erythematosus	0.0139	0.0206	CbGbCtD
Nefazodone—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0121	0.0179	CbGbCtD
Nefazodone—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0121	0.0179	CbGbCtD
Nefazodone—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0104	0.0153	CbGbCtD
Nefazodone—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0102	0.0151	CbGbCtD
Nefazodone—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0101	0.0149	CbGbCtD
Nefazodone—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0097	0.0143	CbGbCtD
Nefazodone—CYP3A4—Prednisone—systemic lupus erythematosus	0.00966	0.0143	CbGbCtD
Nefazodone—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00948	0.014	CbGbCtD
Nefazodone—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00916	0.0135	CbGbCtD
Nefazodone—ABCB1—Methotrexate—systemic lupus erythematosus	0.00809	0.012	CbGbCtD
Nefazodone—HTR2A—choroid plexus—systemic lupus erythematosus	0.00809	0.114	CbGeAlD
Nefazodone—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00603	0.00892	CbGbCtD
Nefazodone—HTR2A—urine—systemic lupus erythematosus	0.00216	0.0305	CbGeAlD
Nefazodone—SLC6A4—blood plasma—systemic lupus erythematosus	0.00213	0.0301	CbGeAlD
Nefazodone—CYP3A4—urine—systemic lupus erythematosus	0.002	0.0282	CbGeAlD
Nefazodone—CYP2D6—urine—systemic lupus erythematosus	0.00197	0.0278	CbGeAlD
Nefazodone—HTR1A—blood plasma—systemic lupus erythematosus	0.0019	0.0267	CbGeAlD
Nefazodone—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.00174	0.0245	CbGeAlD
Nefazodone—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.00149	0.0209	CbGeAlD
Nefazodone—ADRA1B—kidney—systemic lupus erythematosus	0.00141	0.0199	CbGeAlD
Nefazodone—CYP3A5—blood plasma—systemic lupus erythematosus	0.00139	0.0196	CbGeAlD
Nefazodone—ADRA2A—blood plasma—systemic lupus erythematosus	0.00133	0.0187	CbGeAlD
Nefazodone—HTR2A—endothelium—systemic lupus erythematosus	0.00127	0.0179	CbGeAlD
Nefazodone—HTR2A—blood plasma—systemic lupus erythematosus	0.00113	0.0159	CbGeAlD
Nefazodone—CYP3A4—blood plasma—systemic lupus erythematosus	0.00105	0.0147	CbGeAlD
Nefazodone—CYP2D6—blood plasma—systemic lupus erythematosus	0.00103	0.0145	CbGeAlD
Nefazodone—ADRA1B—nervous system—systemic lupus erythematosus	0.000925	0.013	CbGeAlD
Nefazodone—ADRA1B—central nervous system—systemic lupus erythematosus	0.00089	0.0125	CbGeAlD
Nefazodone—SLC6A3—lung—systemic lupus erythematosus	0.000748	0.0105	CbGeAlD
Nefazodone—ABCB1—blood plasma—systemic lupus erythematosus	0.00074	0.0104	CbGeAlD
Nefazodone—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000719	0.0101	CbGeAlD
Nefazodone—ADRA2A—connective tissue—systemic lupus erythematosus	0.000707	0.00996	CbGeAlD
Nefazodone—SLC6A3—nervous system—systemic lupus erythematosus	0.000693	0.00976	CbGeAlD
Nefazodone—SLC6A4—lung—systemic lupus erythematosus	0.000685	0.00966	CbGeAlD
Nefazodone—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.00068	0.00958	CbGeAlD
Nefazodone—HTR2C—nervous system—systemic lupus erythematosus	0.00067	0.00943	CbGeAlD
Nefazodone—SLC6A3—central nervous system—systemic lupus erythematosus	0.000667	0.0094	CbGeAlD
Nefazodone—HTR2C—central nervous system—systemic lupus erythematosus	0.000645	0.00908	CbGeAlD
Nefazodone—SLC6A4—nervous system—systemic lupus erythematosus	0.000635	0.00894	CbGeAlD
Nefazodone—CYP3A5—kidney—systemic lupus erythematosus	0.000631	0.0089	CbGeAlD
Nefazodone—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000615	0.00866	CbGeAlD
Nefazodone—SLC6A4—central nervous system—systemic lupus erythematosus	0.000611	0.00861	CbGeAlD
Nefazodone—SLC6A2—lung—systemic lupus erythematosus	0.000603	0.0085	CbGeAlD
Nefazodone—HTR2A—connective tissue—systemic lupus erythematosus	0.000601	0.00847	CbGeAlD
Nefazodone—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.000586	0.00826	CbGeAlD
Nefazodone—HTR1A—nervous system—systemic lupus erythematosus	0.000564	0.00794	CbGeAlD
Nefazodone—SLC6A2—nervous system—systemic lupus erythematosus	0.000559	0.00787	CbGeAlD
Nefazodone—HTR1A—central nervous system—systemic lupus erythematosus	0.000543	0.00764	CbGeAlD
Nefazodone—SLC6A2—central nervous system—systemic lupus erythematosus	0.000538	0.00758	CbGeAlD
Nefazodone—ADRA1A—nervous system—systemic lupus erythematosus	0.00052	0.00732	CbGeAlD
Nefazodone—HTR2A—kidney—systemic lupus erythematosus	0.000512	0.00721	CbGeAlD
Nefazodone—ADRA1A—central nervous system—systemic lupus erythematosus	0.0005	0.00705	CbGeAlD
Nefazodone—ADRA2A—tendon—systemic lupus erythematosus	0.000486	0.00685	CbGeAlD
Nefazodone—CYP3A4—kidney—systemic lupus erythematosus	0.000474	0.00668	CbGeAlD
Nefazodone—CYP2D6—kidney—systemic lupus erythematosus	0.000466	0.00657	CbGeAlD
Nefazodone—CYP3A5—lung—systemic lupus erythematosus	0.000447	0.0063	CbGeAlD
Nefazodone—ADRA2A—lung—systemic lupus erythematosus	0.000427	0.00601	CbGeAlD
Nefazodone—HTR2A—tendon—systemic lupus erythematosus	0.000413	0.00582	CbGeAlD
Nefazodone—ADRA2A—nervous system—systemic lupus erythematosus	0.000395	0.00557	CbGeAlD
Nefazodone—ABCB1—nephron tubule—systemic lupus erythematosus	0.000382	0.00538	CbGeAlD
Nefazodone—ADRA2A—central nervous system—systemic lupus erythematosus	0.00038	0.00536	CbGeAlD
Nefazodone—HTR2A—lung—systemic lupus erythematosus	0.000363	0.00511	CbGeAlD
Nefazodone—HTR2A—nervous system—systemic lupus erythematosus	0.000336	0.00473	CbGeAlD
Nefazodone—ABCB1—kidney—systemic lupus erythematosus	0.000335	0.00473	CbGeAlD
Nefazodone—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000327	0.0046	CbGeAlD
Nefazodone—HTR2A—central nervous system—systemic lupus erythematosus	0.000323	0.00456	CbGeAlD
Nefazodone—CYP3A4—nervous system—systemic lupus erythematosus	0.000311	0.00438	CbGeAlD
Nefazodone—CYP2D6—nervous system—systemic lupus erythematosus	0.000306	0.00431	CbGeAlD
Nefazodone—CYP3A4—central nervous system—systemic lupus erythematosus	0.000299	0.00422	CbGeAlD
Nefazodone—CYP2D6—central nervous system—systemic lupus erythematosus	0.000295	0.00415	CbGeAlD
Nefazodone—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000288	0.00406	CbGeAlD
Nefazodone—ABCB1—bone marrow—systemic lupus erythematosus	0.000262	0.0037	CbGeAlD
Nefazodone—ABCB1—lung—systemic lupus erythematosus	0.000238	0.00335	CbGeAlD
Nefazodone—ABCB1—nervous system—systemic lupus erythematosus	0.00022	0.0031	CbGeAlD
Nefazodone—ABCB1—central nervous system—systemic lupus erythematosus	0.000212	0.00299	CbGeAlD
Nefazodone—Myalgia—Betamethasone—systemic lupus erythematosus	0.000125	0.000497	CcSEcCtD
Nefazodone—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000125	0.000497	CcSEcCtD
Nefazodone—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000125	0.000496	CcSEcCtD
Nefazodone—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000125	0.000496	CcSEcCtD
Nefazodone—Anxiety—Betamethasone—systemic lupus erythematosus	0.000125	0.000496	CcSEcCtD
Nefazodone—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000125	0.000496	CcSEcCtD
Nefazodone—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000124	0.000491	CcSEcCtD
Nefazodone—Discomfort—Betamethasone—systemic lupus erythematosus	0.000124	0.000491	CcSEcCtD
Nefazodone—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000124	0.000491	CcSEcCtD
Nefazodone—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000124	0.000491	CcSEcCtD
Nefazodone—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000124	0.00049	CcSEcCtD
Nefazodone—Pain—Prednisolone—systemic lupus erythematosus	0.000123	0.000489	CcSEcCtD
Nefazodone—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000123	0.000488	CcSEcCtD
Nefazodone—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000123	0.000488	CcSEcCtD
Nefazodone—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000123	0.000487	CcSEcCtD
Nefazodone—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000122	0.000485	CcSEcCtD
Nefazodone—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000122	0.000485	CcSEcCtD
Nefazodone—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.000484	CcSEcCtD
Nefazodone—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.000484	CcSEcCtD
Nefazodone—Nausea—Leflunomide—systemic lupus erythematosus	0.000122	0.000483	CcSEcCtD
Nefazodone—Vision blurred—Prednisone—systemic lupus erythematosus	0.000121	0.000479	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000121	0.000479	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.00012	0.000478	CcSEcCtD
Nefazodone—Pain—Hydrocortisone—systemic lupus erythematosus	0.00012	0.000477	CcSEcCtD
Nefazodone—Oedema—Betamethasone—systemic lupus erythematosus	0.00012	0.000477	CcSEcCtD
Nefazodone—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.00012	0.000477	CcSEcCtD
Nefazodone—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.00012	0.000477	CcSEcCtD
Nefazodone—Oedema—Dexamethasone—systemic lupus erythematosus	0.00012	0.000477	CcSEcCtD
Nefazodone—Insomnia—Triamcinolone—systemic lupus erythematosus	0.00012	0.000475	CcSEcCtD
Nefazodone—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.00012	0.000474	CcSEcCtD
Nefazodone—Infection—Betamethasone—systemic lupus erythematosus	0.000119	0.000474	CcSEcCtD
Nefazodone—Infection—Dexamethasone—systemic lupus erythematosus	0.000119	0.000474	CcSEcCtD
Nefazodone—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000119	0.000472	CcSEcCtD
Nefazodone—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000119	0.000472	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000119	0.000471	CcSEcCtD
Nefazodone—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000119	0.000471	CcSEcCtD
Nefazodone—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000119	0.000471	CcSEcCtD
Nefazodone—Anaemia—Prednisone—systemic lupus erythematosus	0.000119	0.00047	CcSEcCtD
Nefazodone—Shock—Betamethasone—systemic lupus erythematosus	0.000118	0.000469	CcSEcCtD
Nefazodone—Shock—Dexamethasone—systemic lupus erythematosus	0.000118	0.000469	CcSEcCtD
Nefazodone—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000118	0.000468	CcSEcCtD
Nefazodone—Agitation—Prednisone—systemic lupus erythematosus	0.000118	0.000467	CcSEcCtD
Nefazodone—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000118	0.000467	CcSEcCtD
Nefazodone—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000118	0.000467	CcSEcCtD
Nefazodone—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000117	0.000465	CcSEcCtD
Nefazodone—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000117	0.000465	CcSEcCtD
Nefazodone—Angioedema—Prednisone—systemic lupus erythematosus	0.000117	0.000465	CcSEcCtD
Nefazodone—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000117	0.000463	CcSEcCtD
Nefazodone—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000117	0.000462	CcSEcCtD
Nefazodone—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000116	0.000462	CcSEcCtD
Nefazodone—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000116	0.000461	CcSEcCtD
Nefazodone—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000116	0.000461	CcSEcCtD
Nefazodone—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000116	0.000461	CcSEcCtD
Nefazodone—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000116	0.00046	CcSEcCtD
Nefazodone—Malaise—Prednisone—systemic lupus erythematosus	0.000116	0.000459	CcSEcCtD
Nefazodone—Vertigo—Prednisone—systemic lupus erythematosus	0.000115	0.000457	CcSEcCtD
Nefazodone—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000115	0.000456	CcSEcCtD
Nefazodone—Syncope—Prednisone—systemic lupus erythematosus	0.000115	0.000456	CcSEcCtD
Nefazodone—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000115	0.000455	CcSEcCtD
Nefazodone—Anorexia—Betamethasone—systemic lupus erythematosus	0.000115	0.000454	CcSEcCtD
Nefazodone—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000115	0.000454	CcSEcCtD
Nefazodone—Urticaria—Prednisolone—systemic lupus erythematosus	0.000114	0.000454	CcSEcCtD
Nefazodone—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000114	0.000451	CcSEcCtD
Nefazodone—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000114	0.00045	CcSEcCtD
Nefazodone—Pain—Triamcinolone—systemic lupus erythematosus	0.000113	0.000449	CcSEcCtD
Nefazodone—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000113	0.000447	CcSEcCtD
Nefazodone—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000112	0.000445	CcSEcCtD
Nefazodone—Hypotension—Betamethasone—systemic lupus erythematosus	0.000112	0.000445	CcSEcCtD
Nefazodone—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000112	0.000444	CcSEcCtD
Nefazodone—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000112	0.000443	CcSEcCtD
Nefazodone—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000111	0.000441	CcSEcCtD
Nefazodone—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000111	0.000441	CcSEcCtD
Nefazodone—Convulsion—Prednisone—systemic lupus erythematosus	0.000111	0.000441	CcSEcCtD
Nefazodone—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000111	0.000439	CcSEcCtD
Nefazodone—Hypertension—Prednisone—systemic lupus erythematosus	0.000111	0.000439	CcSEcCtD
Nefazodone—Chills—Methotrexate—systemic lupus erythematosus	0.00011	0.000438	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.00011	0.000434	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.00011	0.000434	CcSEcCtD
Nefazodone—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000109	0.000433	CcSEcCtD
Nefazodone—Myalgia—Prednisone—systemic lupus erythematosus	0.000109	0.000433	CcSEcCtD
Nefazodone—Arthralgia—Prednisone—systemic lupus erythematosus	0.000109	0.000433	CcSEcCtD
Nefazodone—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000109	0.000433	CcSEcCtD
Nefazodone—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000109	0.000432	CcSEcCtD
Nefazodone—Anxiety—Prednisone—systemic lupus erythematosus	0.000109	0.000432	CcSEcCtD
Nefazodone—Alopecia—Methotrexate—systemic lupus erythematosus	0.000109	0.000432	CcSEcCtD
Nefazodone—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000109	0.000431	CcSEcCtD
Nefazodone—Insomnia—Betamethasone—systemic lupus erythematosus	0.000109	0.000431	CcSEcCtD
Nefazodone—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000108	0.00043	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000108	0.000429	CcSEcCtD
Nefazodone—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000108	0.000428	CcSEcCtD
Nefazodone—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000108	0.000428	CcSEcCtD
Nefazodone—Discomfort—Prednisone—systemic lupus erythematosus	0.000108	0.000428	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000106	0.000421	CcSEcCtD
Nefazodone—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000106	0.00042	CcSEcCtD
Nefazodone—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000106	0.00042	CcSEcCtD
Nefazodone—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000106	0.000419	CcSEcCtD
Nefazodone—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000105	0.000417	CcSEcCtD
Nefazodone—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000105	0.000416	CcSEcCtD
Nefazodone—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000105	0.000416	CcSEcCtD
Nefazodone—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000105	0.000415	CcSEcCtD
Nefazodone—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000105	0.000415	CcSEcCtD
Nefazodone—Oedema—Prednisone—systemic lupus erythematosus	0.000105	0.000415	CcSEcCtD
Nefazodone—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000105	0.000415	CcSEcCtD
Nefazodone—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000104	0.000414	CcSEcCtD
Nefazodone—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000104	0.000414	CcSEcCtD
Nefazodone—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000104	0.000414	CcSEcCtD
Nefazodone—Infection—Prednisone—systemic lupus erythematosus	0.000104	0.000412	CcSEcCtD
Nefazodone—Back pain—Methotrexate—systemic lupus erythematosus	0.000104	0.000411	CcSEcCtD
Nefazodone—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000104	0.000411	CcSEcCtD
Nefazodone—Shock—Prednisone—systemic lupus erythematosus	0.000103	0.000408	CcSEcCtD
Nefazodone—Pain—Betamethasone—systemic lupus erythematosus	0.000103	0.000408	CcSEcCtD
Nefazodone—Pain—Dexamethasone—systemic lupus erythematosus	0.000103	0.000408	CcSEcCtD
Nefazodone—Tachycardia—Prednisone—systemic lupus erythematosus	0.000102	0.000405	CcSEcCtD
Nefazodone—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000102	0.000405	CcSEcCtD
Nefazodone—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000101	0.000401	CcSEcCtD
Nefazodone—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000101	0.000401	CcSEcCtD
Nefazodone—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000101	0.0004	CcSEcCtD
Nefazodone—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000101	0.000399	CcSEcCtD
Nefazodone—Rash—Cyclosporine—systemic lupus erythematosus	9.98e-05	0.000396	CcSEcCtD
Nefazodone—Anorexia—Prednisone—systemic lupus erythematosus	9.98e-05	0.000396	CcSEcCtD
Nefazodone—Dermatitis—Cyclosporine—systemic lupus erythematosus	9.97e-05	0.000395	CcSEcCtD
Nefazodone—Pruritus—Hydrocortisone—systemic lupus erythematosus	9.95e-05	0.000395	CcSEcCtD
Nefazodone—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	9.95e-05	0.000394	CcSEcCtD
Nefazodone—Headache—Cyclosporine—systemic lupus erythematosus	9.92e-05	0.000393	CcSEcCtD
Nefazodone—Anaemia—Methotrexate—systemic lupus erythematosus	9.91e-05	0.000393	CcSEcCtD
Nefazodone—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	9.91e-05	0.000393	CcSEcCtD
Nefazodone—Feeling abnormal—Betamethasone—systemic lupus erythematosus	9.91e-05	0.000393	CcSEcCtD
Nefazodone—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	9.83e-05	0.00039	CcSEcCtD
Nefazodone—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	9.83e-05	0.00039	CcSEcCtD
Nefazodone—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	9.82e-05	0.000389	CcSEcCtD
Nefazodone—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	9.76e-05	0.000387	CcSEcCtD
Nefazodone—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	9.74e-05	0.000386	CcSEcCtD
Nefazodone—Rash—Mycophenolate mofetil—systemic lupus erythematosus	9.74e-05	0.000386	CcSEcCtD
Nefazodone—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	9.73e-05	0.000386	CcSEcCtD
Nefazodone—Headache—Mycophenolate mofetil—systemic lupus erythematosus	9.67e-05	0.000384	CcSEcCtD
Nefazodone—Malaise—Methotrexate—systemic lupus erythematosus	9.67e-05	0.000383	CcSEcCtD
Nefazodone—Vertigo—Methotrexate—systemic lupus erythematosus	9.63e-05	0.000382	CcSEcCtD
Nefazodone—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	9.63e-05	0.000382	CcSEcCtD
Nefazodone—Leukopenia—Methotrexate—systemic lupus erythematosus	9.6e-05	0.000381	CcSEcCtD
Nefazodone—Urticaria—Betamethasone—systemic lupus erythematosus	9.55e-05	0.000379	CcSEcCtD
Nefazodone—Urticaria—Dexamethasone—systemic lupus erythematosus	9.55e-05	0.000379	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	9.54e-05	0.000378	CcSEcCtD
Nefazodone—Dizziness—Prednisolone—systemic lupus erythematosus	9.53e-05	0.000378	CcSEcCtD
Nefazodone—Asthenia—Triamcinolone—systemic lupus erythematosus	9.5e-05	0.000377	CcSEcCtD
Nefazodone—Body temperature increased—Dexamethasone—systemic lupus erythematosus	9.5e-05	0.000377	CcSEcCtD
Nefazodone—Body temperature increased—Betamethasone—systemic lupus erythematosus	9.5e-05	0.000377	CcSEcCtD
Nefazodone—Abdominal pain—Dexamethasone—systemic lupus erythematosus	9.5e-05	0.000377	CcSEcCtD
Nefazodone—Abdominal pain—Betamethasone—systemic lupus erythematosus	9.5e-05	0.000377	CcSEcCtD
Nefazodone—Asthenia—Methylprednisolone—systemic lupus erythematosus	9.48e-05	0.000376	CcSEcCtD
Nefazodone—Insomnia—Prednisone—systemic lupus erythematosus	9.47e-05	0.000375	CcSEcCtD
Nefazodone—Nausea—Cyclosporine—systemic lupus erythematosus	9.4e-05	0.000373	CcSEcCtD
Nefazodone—Paraesthesia—Prednisone—systemic lupus erythematosus	9.4e-05	0.000373	CcSEcCtD
Nefazodone—Pruritus—Triamcinolone—systemic lupus erythematosus	9.37e-05	0.000372	CcSEcCtD
Nefazodone—Cough—Methotrexate—systemic lupus erythematosus	9.35e-05	0.000371	CcSEcCtD
Nefazodone—Pruritus—Methylprednisolone—systemic lupus erythematosus	9.35e-05	0.000371	CcSEcCtD
Nefazodone—Dizziness—Hydrocortisone—systemic lupus erythematosus	9.3e-05	0.000369	CcSEcCtD
Nefazodone—Convulsion—Methotrexate—systemic lupus erythematosus	9.29e-05	0.000368	CcSEcCtD
Nefazodone—Dyspepsia—Prednisone—systemic lupus erythematosus	9.21e-05	0.000365	CcSEcCtD
Nefazodone—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	9.17e-05	0.000364	CcSEcCtD
Nefazodone—Chest pain—Methotrexate—systemic lupus erythematosus	9.13e-05	0.000362	CcSEcCtD
Nefazodone—Arthralgia—Methotrexate—systemic lupus erythematosus	9.13e-05	0.000362	CcSEcCtD
Nefazodone—Myalgia—Methotrexate—systemic lupus erythematosus	9.13e-05	0.000362	CcSEcCtD
Nefazodone—Decreased appetite—Prednisone—systemic lupus erythematosus	9.1e-05	0.000361	CcSEcCtD
Nefazodone—Rash—Prednisolone—systemic lupus erythematosus	9.08e-05	0.00036	CcSEcCtD
Nefazodone—Dermatitis—Prednisolone—systemic lupus erythematosus	9.07e-05	0.00036	CcSEcCtD
Nefazodone—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	9.04e-05	0.000359	CcSEcCtD
Nefazodone—Headache—Prednisolone—systemic lupus erythematosus	9.02e-05	0.000358	CcSEcCtD
Nefazodone—Discomfort—Methotrexate—systemic lupus erythematosus	9.02e-05	0.000358	CcSEcCtD
Nefazodone—Constipation—Prednisone—systemic lupus erythematosus	8.95e-05	0.000355	CcSEcCtD
Nefazodone—Vomiting—Hydrocortisone—systemic lupus erythematosus	8.95e-05	0.000355	CcSEcCtD
Nefazodone—Rash—Hydrocortisone—systemic lupus erythematosus	8.87e-05	0.000352	CcSEcCtD
Nefazodone—Dermatitis—Hydrocortisone—systemic lupus erythematosus	8.86e-05	0.000351	CcSEcCtD
Nefazodone—Confusional state—Methotrexate—systemic lupus erythematosus	8.82e-05	0.00035	CcSEcCtD
Nefazodone—Headache—Hydrocortisone—systemic lupus erythematosus	8.81e-05	0.00035	CcSEcCtD
Nefazodone—Dizziness—Triamcinolone—systemic lupus erythematosus	8.76e-05	0.000347	CcSEcCtD
Nefazodone—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	8.75e-05	0.000347	CcSEcCtD
Nefazodone—Dizziness—Methylprednisolone—systemic lupus erythematosus	8.74e-05	0.000347	CcSEcCtD
Nefazodone—Infection—Methotrexate—systemic lupus erythematosus	8.69e-05	0.000345	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisone—systemic lupus erythematosus	8.63e-05	0.000342	CcSEcCtD
Nefazodone—Asthenia—Dexamethasone—systemic lupus erythematosus	8.62e-05	0.000342	CcSEcCtD
Nefazodone—Asthenia—Betamethasone—systemic lupus erythematosus	8.62e-05	0.000342	CcSEcCtD
Nefazodone—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	8.57e-05	0.00034	CcSEcCtD
Nefazodone—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	8.56e-05	0.000339	CcSEcCtD
Nefazodone—Nausea—Prednisolone—systemic lupus erythematosus	8.56e-05	0.000339	CcSEcCtD
Nefazodone—Pruritus—Dexamethasone—systemic lupus erythematosus	8.5e-05	0.000337	CcSEcCtD
Nefazodone—Pruritus—Betamethasone—systemic lupus erythematosus	8.5e-05	0.000337	CcSEcCtD
Nefazodone—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	8.46e-05	0.000335	CcSEcCtD
Nefazodone—Vomiting—Triamcinolone—systemic lupus erythematosus	8.42e-05	0.000334	CcSEcCtD
Nefazodone—Vomiting—Methylprednisolone—systemic lupus erythematosus	8.4e-05	0.000333	CcSEcCtD
Nefazodone—Nausea—Hydrocortisone—systemic lupus erythematosus	8.36e-05	0.000331	CcSEcCtD
Nefazodone—Rash—Triamcinolone—systemic lupus erythematosus	8.35e-05	0.000331	CcSEcCtD
Nefazodone—Dermatitis—Triamcinolone—systemic lupus erythematosus	8.35e-05	0.000331	CcSEcCtD
Nefazodone—Anorexia—Methotrexate—systemic lupus erythematosus	8.34e-05	0.000331	CcSEcCtD
Nefazodone—Rash—Methylprednisolone—systemic lupus erythematosus	8.33e-05	0.000331	CcSEcCtD
Nefazodone—Dermatitis—Methylprednisolone—systemic lupus erythematosus	8.33e-05	0.00033	CcSEcCtD
Nefazodone—Urticaria—Prednisone—systemic lupus erythematosus	8.32e-05	0.00033	CcSEcCtD
Nefazodone—Headache—Triamcinolone—systemic lupus erythematosus	8.3e-05	0.000329	CcSEcCtD
Nefazodone—Headache—Methylprednisolone—systemic lupus erythematosus	8.28e-05	0.000328	CcSEcCtD
Nefazodone—Body temperature increased—Prednisone—systemic lupus erythematosus	8.28e-05	0.000328	CcSEcCtD
Nefazodone—Abdominal pain—Prednisone—systemic lupus erythematosus	8.28e-05	0.000328	CcSEcCtD
Nefazodone—Diarrhoea—Betamethasone—systemic lupus erythematosus	8.22e-05	0.000326	CcSEcCtD
Nefazodone—Diarrhoea—Dexamethasone—systemic lupus erythematosus	8.22e-05	0.000326	CcSEcCtD
Nefazodone—Hypotension—Methotrexate—systemic lupus erythematosus	8.17e-05	0.000324	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	7.97e-05	0.000316	CcSEcCtD
Nefazodone—Dizziness—Dexamethasone—systemic lupus erythematosus	7.95e-05	0.000315	CcSEcCtD
Nefazodone—Dizziness—Betamethasone—systemic lupus erythematosus	7.95e-05	0.000315	CcSEcCtD
Nefazodone—Insomnia—Methotrexate—systemic lupus erythematosus	7.91e-05	0.000314	CcSEcCtD
Nefazodone—Nausea—Triamcinolone—systemic lupus erythematosus	7.87e-05	0.000312	CcSEcCtD
Nefazodone—Paraesthesia—Methotrexate—systemic lupus erythematosus	7.86e-05	0.000312	CcSEcCtD
Nefazodone—Nausea—Methylprednisolone—systemic lupus erythematosus	7.85e-05	0.000311	CcSEcCtD
Nefazodone—Dyspnoea—Methotrexate—systemic lupus erythematosus	7.8e-05	0.000309	CcSEcCtD
Nefazodone—Somnolence—Methotrexate—systemic lupus erythematosus	7.78e-05	0.000308	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisone—systemic lupus erythematosus	7.71e-05	0.000306	CcSEcCtD
Nefazodone—Dyspepsia—Methotrexate—systemic lupus erythematosus	7.7e-05	0.000305	CcSEcCtD
Nefazodone—Vomiting—Dexamethasone—systemic lupus erythematosus	7.64e-05	0.000303	CcSEcCtD
Nefazodone—Vomiting—Betamethasone—systemic lupus erythematosus	7.64e-05	0.000303	CcSEcCtD
Nefazodone—Decreased appetite—Methotrexate—systemic lupus erythematosus	7.61e-05	0.000302	CcSEcCtD
Nefazodone—Rash—Dexamethasone—systemic lupus erythematosus	7.58e-05	0.000301	CcSEcCtD
Nefazodone—Rash—Betamethasone—systemic lupus erythematosus	7.58e-05	0.000301	CcSEcCtD
Nefazodone—Dermatitis—Betamethasone—systemic lupus erythematosus	7.57e-05	0.0003	CcSEcCtD
Nefazodone—Dermatitis—Dexamethasone—systemic lupus erythematosus	7.57e-05	0.0003	CcSEcCtD
Nefazodone—Headache—Betamethasone—systemic lupus erythematosus	7.53e-05	0.000299	CcSEcCtD
Nefazodone—Headache—Dexamethasone—systemic lupus erythematosus	7.53e-05	0.000299	CcSEcCtD
Nefazodone—Asthenia—Prednisone—systemic lupus erythematosus	7.51e-05	0.000298	CcSEcCtD
Nefazodone—Pain—Methotrexate—systemic lupus erythematosus	7.48e-05	0.000297	CcSEcCtD
Nefazodone—Pruritus—Prednisone—systemic lupus erythematosus	7.41e-05	0.000294	CcSEcCtD
Nefazodone—Feeling abnormal—Methotrexate—systemic lupus erythematosus	7.21e-05	0.000286	CcSEcCtD
Nefazodone—Diarrhoea—Prednisone—systemic lupus erythematosus	7.16e-05	0.000284	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	7.15e-05	0.000284	CcSEcCtD
Nefazodone—Nausea—Dexamethasone—systemic lupus erythematosus	7.14e-05	0.000283	CcSEcCtD
Nefazodone—Nausea—Betamethasone—systemic lupus erythematosus	7.14e-05	0.000283	CcSEcCtD
Nefazodone—Urticaria—Methotrexate—systemic lupus erythematosus	6.95e-05	0.000276	CcSEcCtD
Nefazodone—Dizziness—Prednisone—systemic lupus erythematosus	6.92e-05	0.000275	CcSEcCtD
Nefazodone—Abdominal pain—Methotrexate—systemic lupus erythematosus	6.92e-05	0.000274	CcSEcCtD
Nefazodone—Body temperature increased—Methotrexate—systemic lupus erythematosus	6.92e-05	0.000274	CcSEcCtD
Nefazodone—Vomiting—Prednisone—systemic lupus erythematosus	6.66e-05	0.000264	CcSEcCtD
Nefazodone—Rash—Prednisone—systemic lupus erythematosus	6.6e-05	0.000262	CcSEcCtD
Nefazodone—Dermatitis—Prednisone—systemic lupus erythematosus	6.59e-05	0.000262	CcSEcCtD
Nefazodone—Headache—Prednisone—systemic lupus erythematosus	6.56e-05	0.00026	CcSEcCtD
Nefazodone—Hypersensitivity—Methotrexate—systemic lupus erythematosus	6.45e-05	0.000256	CcSEcCtD
Nefazodone—Asthenia—Methotrexate—systemic lupus erythematosus	6.28e-05	0.000249	CcSEcCtD
Nefazodone—Nausea—Prednisone—systemic lupus erythematosus	6.22e-05	0.000247	CcSEcCtD
Nefazodone—Pruritus—Methotrexate—systemic lupus erythematosus	6.19e-05	0.000245	CcSEcCtD
Nefazodone—Diarrhoea—Methotrexate—systemic lupus erythematosus	5.99e-05	0.000237	CcSEcCtD
Nefazodone—Dizziness—Methotrexate—systemic lupus erythematosus	5.79e-05	0.000229	CcSEcCtD
Nefazodone—Vomiting—Methotrexate—systemic lupus erythematosus	5.56e-05	0.000221	CcSEcCtD
Nefazodone—Rash—Methotrexate—systemic lupus erythematosus	5.52e-05	0.000219	CcSEcCtD
Nefazodone—Dermatitis—Methotrexate—systemic lupus erythematosus	5.51e-05	0.000219	CcSEcCtD
Nefazodone—Headache—Methotrexate—systemic lupus erythematosus	5.48e-05	0.000217	CcSEcCtD
Nefazodone—Nausea—Methotrexate—systemic lupus erythematosus	5.2e-05	0.000206	CcSEcCtD
Nefazodone—HTR2A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	5.27e-07	0.000541	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	5.26e-07	0.000541	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—F2—systemic lupus erythematosus	5.23e-07	0.000537	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—F2—systemic lupus erythematosus	5.2e-07	0.000534	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL2RA—systemic lupus erythematosus	5.19e-07	0.000534	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	5.19e-07	0.000533	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—NOS3—systemic lupus erythematosus	5.17e-07	0.000531	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	5.16e-07	0.00053	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NCF2—systemic lupus erythematosus	5.16e-07	0.00053	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—C3—systemic lupus erythematosus	5.15e-07	0.000529	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.15e-07	0.000529	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—C3—systemic lupus erythematosus	5.15e-07	0.000529	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CSK—systemic lupus erythematosus	5.13e-07	0.000527	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—LYN—systemic lupus erythematosus	5.12e-07	0.000526	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	5.08e-07	0.000522	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	5.06e-07	0.000519	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NCF2—systemic lupus erythematosus	5.05e-07	0.000519	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	5.05e-07	0.000518	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—C3—systemic lupus erythematosus	5.04e-07	0.000518	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	5.02e-07	0.000516	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—LYN—systemic lupus erythematosus	5.01e-07	0.000515	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—F2—systemic lupus erythematosus	4.98e-07	0.000512	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.94e-07	0.000508	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.92e-07	0.000505	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—RXRA—systemic lupus erythematosus	4.89e-07	0.000502	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	4.81e-07	0.000494	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	4.79e-07	0.000492	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.78e-07	0.000491	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.77e-07	0.00049	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	4.76e-07	0.000489	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—F2—systemic lupus erythematosus	4.75e-07	0.000488	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.75e-07	0.000488	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—F2—systemic lupus erythematosus	4.72e-07	0.000485	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	4.72e-07	0.000485	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.71e-07	0.000484	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NCF2—systemic lupus erythematosus	4.69e-07	0.000482	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—JUNB—systemic lupus erythematosus	4.68e-07	0.000481	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.68e-07	0.000481	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—C3—systemic lupus erythematosus	4.68e-07	0.000481	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—C3—systemic lupus erythematosus	4.67e-07	0.00048	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—LYN—systemic lupus erythematosus	4.66e-07	0.000479	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—JUNB—systemic lupus erythematosus	4.66e-07	0.000479	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.61e-07	0.000474	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.59e-07	0.000472	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—C3—systemic lupus erythematosus	4.58e-07	0.00047	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.57e-07	0.00047	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.54e-07	0.000467	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—F2—systemic lupus erythematosus	4.52e-07	0.000465	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—F2—systemic lupus erythematosus	4.52e-07	0.000464	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	4.48e-07	0.000461	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—JUNB—systemic lupus erythematosus	4.46e-07	0.000458	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.45e-07	0.000457	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.43e-07	0.000455	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—F2—systemic lupus erythematosus	4.42e-07	0.000454	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—IL2—systemic lupus erythematosus	4.38e-07	0.00045	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.35e-07	0.000447	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PRL—systemic lupus erythematosus	4.31e-07	0.000443	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PRL—systemic lupus erythematosus	4.29e-07	0.000441	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.29e-07	0.00044	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—C3—systemic lupus erythematosus	4.25e-07	0.000437	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.24e-07	0.000435	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.23e-07	0.000435	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.21e-07	0.000433	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.12e-07	0.000423	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—F2—systemic lupus erythematosus	4.11e-07	0.000422	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PRL—systemic lupus erythematosus	4.11e-07	0.000422	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—F2—systemic lupus erythematosus	4.1e-07	0.000421	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—JUNB—systemic lupus erythematosus	4.05e-07	0.000416	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.04e-07	0.000415	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.03e-07	0.000414	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—F2—systemic lupus erythematosus	4.02e-07	0.000413	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—JUNB—systemic lupus erythematosus	3.96e-07	0.000407	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—EP300—systemic lupus erythematosus	3.93e-07	0.000404	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—RXRA—systemic lupus erythematosus	3.86e-07	0.000396	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.84e-07	0.000395	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.84e-07	0.000395	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.82e-07	0.000393	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.76e-07	0.000387	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.75e-07	0.000385	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—F2—systemic lupus erythematosus	3.73e-07	0.000383	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PRL—systemic lupus erythematosus	3.73e-07	0.000383	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—VEGFA—systemic lupus erythematosus	3.72e-07	0.000382	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—JUNB—systemic lupus erythematosus	3.68e-07	0.000378	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.66e-07	0.000376	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.66e-07	0.000376	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PRL—systemic lupus erythematosus	3.65e-07	0.000375	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.58e-07	0.000368	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	3.53e-07	0.000363	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.52e-07	0.000362	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.5e-07	0.00036	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.5e-07	0.000359	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—JAK1—systemic lupus erythematosus	3.45e-07	0.000354	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—JAK1—systemic lupus erythematosus	3.43e-07	0.000353	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TGFB1—systemic lupus erythematosus	3.42e-07	0.000351	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PRL—systemic lupus erythematosus	3.39e-07	0.000348	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.35e-07	0.000345	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.33e-07	0.000342	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.32e-07	0.000341	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—JAK1—systemic lupus erythematosus	3.29e-07	0.000338	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCR5—systemic lupus erythematosus	3.27e-07	0.000336	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCR5—systemic lupus erythematosus	3.25e-07	0.000334	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.25e-07	0.000334	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.23e-07	0.000332	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.22e-07	0.000331	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.21e-07	0.000329	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL2—systemic lupus erythematosus	3.2e-07	0.000329	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—C3—systemic lupus erythematosus	3.2e-07	0.000328	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL2—systemic lupus erythematosus	3.18e-07	0.000327	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—C3—systemic lupus erythematosus	3.18e-07	0.000327	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCR5—systemic lupus erythematosus	3.11e-07	0.00032	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PPARG—systemic lupus erythematosus	3.09e-07	0.000317	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.07e-07	0.000315	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL2—systemic lupus erythematosus	3.05e-07	0.000313	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—C3—systemic lupus erythematosus	3.04e-07	0.000313	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.04e-07	0.000313	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.02e-07	0.00031	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—JAK1—systemic lupus erythematosus	2.98e-07	0.000306	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.98e-07	0.000306	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	2.93e-07	0.000301	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—JAK1—systemic lupus erythematosus	2.92e-07	0.0003	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCR5—systemic lupus erythematosus	2.82e-07	0.00029	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—F2—systemic lupus erythematosus	2.81e-07	0.000288	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—F2—systemic lupus erythematosus	2.79e-07	0.000287	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.78e-07	0.000286	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ALB—systemic lupus erythematosus	2.78e-07	0.000285	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.77e-07	0.000284	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCR5—systemic lupus erythematosus	2.77e-07	0.000284	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL2—systemic lupus erythematosus	2.76e-07	0.000284	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—C3—systemic lupus erythematosus	2.76e-07	0.000284	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.73e-07	0.00028	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—JAK1—systemic lupus erythematosus	2.71e-07	0.000279	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL2—systemic lupus erythematosus	2.71e-07	0.000278	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—C3—systemic lupus erythematosus	2.7e-07	0.000278	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CD80—systemic lupus erythematosus	2.69e-07	0.000276	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CD80—systemic lupus erythematosus	2.68e-07	0.000275	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—F2—systemic lupus erythematosus	2.67e-07	0.000274	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	2.67e-07	0.000274	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—NOS3—systemic lupus erythematosus	2.66e-07	0.000273	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCR5—systemic lupus erythematosus	2.57e-07	0.000264	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CD80—systemic lupus erythematosus	2.56e-07	0.000263	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.53e-07	0.00026	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	2.51e-07	0.000258	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	2.51e-07	0.000258	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—C3—systemic lupus erythematosus	2.51e-07	0.000258	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.5e-07	0.000257	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL2—systemic lupus erythematosus	2.49e-07	0.000256	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PPARG—systemic lupus erythematosus	2.44e-07	0.00025	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTGS2—systemic lupus erythematosus	2.43e-07	0.00025	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—F2—systemic lupus erythematosus	2.42e-07	0.000249	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL2—systemic lupus erythematosus	2.38e-07	0.000245	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—F2—systemic lupus erythematosus	2.37e-07	0.000244	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	2.32e-07	0.000239	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	2.28e-07	0.000234	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.27e-07	0.000233	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	2.26e-07	0.000232	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	2.23e-07	0.000229	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.23e-07	0.000229	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	2.22e-07	0.000228	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	2.2e-07	0.000227	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	2.19e-07	0.000225	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	2.16e-07	0.000222	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.16e-07	0.000222	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	2.12e-07	0.000218	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.12e-07	0.000217	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	2.11e-07	0.000217	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	2.09e-07	0.000215	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—EP300—systemic lupus erythematosus	2.02e-07	0.000208	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	2.01e-07	0.000206	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.97e-07	0.000202	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.96e-07	0.000202	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.93e-07	0.000198	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.93e-07	0.000198	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.92e-07	0.000197	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.92e-07	0.000197	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	1.92e-07	0.000197	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	1.92e-07	0.000197	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2—systemic lupus erythematosus	1.89e-07	0.000194	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.89e-07	0.000194	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.88e-07	0.000193	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	1.88e-07	0.000193	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	1.87e-07	0.000192	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.84e-07	0.000189	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	1.8e-07	0.000185	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	1.79e-07	0.000184	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.79e-07	0.000184	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.78e-07	0.000183	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.78e-07	0.000183	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	1.78e-07	0.000183	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.77e-07	0.000182	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	1.76e-07	0.00018	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.75e-07	0.00018	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	1.7e-07	0.000175	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.7e-07	0.000174	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—EP300—systemic lupus erythematosus	1.7e-07	0.000174	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	1.69e-07	0.000173	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.68e-07	0.000173	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.67e-07	0.000171	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.64e-07	0.000169	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.63e-07	0.000168	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	1.63e-07	0.000168	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.62e-07	0.000167	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	1.61e-07	0.000166	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.61e-07	0.000165	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	1.6e-07	0.000164	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.6e-07	0.000164	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	1.59e-07	0.000164	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.59e-07	0.000163	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.59e-07	0.000163	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.54e-07	0.000159	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.54e-07	0.000158	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.53e-07	0.000157	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.52e-07	0.000156	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.51e-07	0.000156	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.51e-07	0.000155	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.51e-07	0.000155	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	1.48e-07	0.000153	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.48e-07	0.000152	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.47e-07	0.000151	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.47e-07	0.000151	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	1.46e-07	0.00015	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	1.46e-07	0.00015	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.45e-07	0.000149	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	1.43e-07	0.000147	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.43e-07	0.000147	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.41e-07	0.000144	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.4e-07	0.000144	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.4e-07	0.000144	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.39e-07	0.000142	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.36e-07	0.00014	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.36e-07	0.00014	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	1.33e-07	0.000137	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.32e-07	0.000136	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.27e-07	0.000131	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.26e-07	0.00013	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.25e-07	0.000128	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.25e-07	0.000128	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.16e-07	0.000119	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—systemic lupus erythematosus	1.11e-07	0.000114	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	1.1e-07	0.000113	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.1e-07	0.000113	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	1.06e-07	0.000109	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.04e-07	0.000107	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.04e-07	0.000107	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	9.59e-08	9.86e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	9.39e-08	9.65e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	9.33e-08	9.58e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	8.92e-08	9.17e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	8.73e-08	8.97e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	8.16e-08	8.39e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	6.79e-08	6.97e-05	CbGpPWpGaD
